Atlas Trials

A Database Study of Maralixibat (TAK-625) in Participants With Alagille Syndrome (ALGS) and Progressive Familial Intrahepatic Cholestasis (PFIC)

Clinical trial NCT07293897 · RECRUITING

Trial details

NCT number
NCT07293897
Sponsor
Takeda
Status
RECRUITING
Study type
OBSERVATIONAL
Alagille Syndrome (ALGS)Progressive Familial Intrahepatic Cholestasis (PFIC)
Start date
2026-01-13
Primary completion
2031-06-30
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.